Skip to main content

Table 1 Patient and tophus characteristics at the time of surgerya

From: Bone destruction by receptor activator of nuclear factor κB ligand-expressing T cells in chronic gouty arthritis

Patient characteristics (n = 8)

 

   No. (%) male

7 (88)

   Age, median (range) years

46 (31 to 67)

Duration of gout, median (range) years

12 (4 to 30)

No. (%) prescribed allopurinol

6 (75)

No. (%) prescribed colchicine

7 (87.5)

No. (%) prescribed nonsteroidal anti-inflammatory drugs

2 (25)

   Serum urate, median (range) mg/dl

6.6 (5 to 9.8)

   CRP, median (range) mg/dl

0.84 (0.2 to 4.3)

Tophus characteristics (n = 14)

 

   Duration of tophus, median (range) years

5 (1.5 to 7)

Location of tophus

 

   First MTP joint, No. (%)

7 (50)

   Ankle joint, No. (%)

4 (29)

   Elbow joint, No. (%)

2 (14)

   Hand PIP joint, No. (%)

1 (7)

Indication for surgery

 

   Mechanical problem, No. (%)

10 (71)

   Pain control, No. (%)

4 (28)

Sepsis control (infected/ulcerated tophi), No. (%)

0 (0)

  1. CRP, C-reactive protein; MTP, metatarsophalangeal; No., number; PIP, proximal interphalangeal. aData are presented as medians and ranges or percentages.